The function of MHC-II expression in tumor cells has long been unknown; recently, several studies have demonstrated that CD4 T cells can recognize melanoma cells in an antigen-specific, MHC class II-dependent manner (19–21). This evidence concerns the gene CD4 and neoplasm.